Patient Reinforcement Plans™ demonstrated significant effects in
participant population:

Key Value Drivers:

• Decrease in non-adherence
• Decrease in clinical markers of disease severity (see graph)
• Adherence “Spillover” effect to medications not included in program
• Trend towards reduction in ER visits
• Reduced incentive budget